Cardiomyopathy: Difference between revisions
Jump to navigation
Jump to search
| Line 34: | Line 34: | ||
:[[Dilated cardiomyopathy]] | :[[Dilated cardiomyopathy]] | ||
:[[Hypertrophic obstructive cardiomyopathy]] | :[[Hypertrophic obstructive cardiomyopathy]] | ||
:[[Noncompaction cardiomyopathy]] | |||
:[[Tachycardia induced cardiomyopathy]] | :[[Tachycardia induced cardiomyopathy]] | ||
Revision as of 17:31, 16 October 2011
For patient information click here
| Cardiomyopathy | |
 | |
|---|---|
| Opened left ventricle of heart shows a thickened, dilated left ventricle with subendocardial fibrosis manifested as increased whiteness of endocardium {Autopsy findings}. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | I42.0 |
| ICD-9 | 425.4 |
| DiseasesDB | 2137 |
| MeSH | D009202 |
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Classification
Pathophysiology
Epidemiology & Demographics
Risk Factors
Causes of Cardiomyopathy
- Dilated cardiomyopathy
- Hypertrophic obstructive cardiomyopathy
- Noncompaction cardiomyopathy
- Tachycardia induced cardiomyopathy
Differentiating Cardiomyopathy from other Diseases
Natural History, Complications & Prognosis
Treatment
External links
- The Cardiomyopathy Association
- Cardiomyopathy information from Seattle Children's Hospital Heart Center
- Information from the Stanford Hypertrophic Cardiomyopathy Center
- Cardiomyopathy-related antibodies
de:Kardiomyopathie nl:Cardiomyopathie no:Kardiomyopati simple:Cardiomyopathy sr:Кардиомиопатија sv:Hjärtmuskelsjukdom